UV-independent p53 mutations in sebaceous carcinoma of the eyelid

Ophthalmic Plastic and Reconstructive Surgery

Volumn 30, Issue 5, 2014, Pages 392-395

  Hussain, Rehan M ^a   Matthews, Jared L ^a   Dubovy, Sander R ^a,b   Thompson, Jordan M ^a   Wang, Gaofeng ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; EYELID CARCINOMA; FEMALE; GENE MUTATION; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SEBACEOUS CARCINOMA; TUMOR INVASION; TUMOR VOLUME; ULTRAVIOLET RADIATION; VERY ELDERLY; ADENOCARCINOMA; EYELID TUMOR; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; SEBACEOUS GLAND TUMOR;

ADENOCARCINOMA, SEBACEOUS; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EYELID NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SEBACEOUS GLAND NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 84914690763     PISSN: 07409303     EISSN: 15372677     Source Type: Journal    
DOI: 10.1097/IOP.0000000000000121     Document Type: Article

References (14)

1. Izumi M, Tang X, Chiu CS, et al. Ten cases of sebaceous carcinoma arising in nevus sebaceous. J Dermatol 2008;35:704-11.
2. Shalin SC, Sakharpe A, Lyle S, et al. p53 staining correlates with tumor type and location in sebaceous neoplasms. Am J Dermatopathol 2012;34:129-35.
3. Gonzalez-Fernandez F, Kaltreider SA, Patnaik BD, et al. Sebaceous carcinoma. tumor progression through mutational inactivation of p53. Ophthalmology 1998;105:497-506.
4. Sung D, Kaltreider SA, Gonzalez-Fernandez F. Early onset sebaceous carcinoma. Diagn Pathol 2011;6:81.
5. Yen MT, Tse DT. Sebaceous cell carcinoma of the eyelid and the human immunodeficiency virus. Ophthal Plast Reconstr Surg 2000;16:206-10.
6. Kivela T, Asko-Seljavaara S, Pihkala U, et al. Sebaceous carcinoma of the eyelid associated with retinoblastoma. Ophthalmology 2001;108:1124-8.
7. Karcioglu ZA. Sebaceous carcinoma of the eyelids. Ophthalmology 2005;112:1641, author reply 1641-2.
8. Harris C. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 1996;88:1442-55.
9. Kiyosaki K, Nakada C, Hijiya N, et al. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. Invest Ophthalmol Vis Sci 2010;51:7-11.
10. Reszec J, Sulkowska M, Koda M, et al. Expression of cell proliferation and apoptosis markers in papillomas and cancers of conjunctiva and eyelid. Ann N Y Acad Sci 2004;1030:419-26.
11. Niu Y, Wang H, Ji J, et al. A study on expressions of p53 protein and proliferating cell nuclear antigen in malignant eyelid tumors. Zhonghua Yan Ke Za Zhi 1999;35:36-9, 5.
12. Duddy PM, Hanby AM, Barnes DM, et al. Improving the detection of p53 mutations in breast cancer by use of the fasay, a functional assay. J Mol Diagn 2000;2:139-44.
13. Shields JA, Demirci H, Marr B P, et al. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 2004;111:2151-7.
14. Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer 2009;115:158-65.